| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epilepsy | 75 | 2025 | 859 | 9.350 |
Why?
|
| Epilepsy, Absence | 15 | 2020 | 31 | 4.490 |
Why?
|
| Seizures | 44 | 2023 | 871 | 3.190 |
Why?
|
| Neurons | 43 | 2024 | 1927 | 2.640 |
Why?
|
| Calcium Channels | 20 | 2018 | 159 | 2.490 |
Why?
|
| Death, Sudden | 8 | 2019 | 45 | 2.400 |
Why?
|
| Thalamus | 8 | 2020 | 85 | 2.330 |
Why?
|
| Cerebral Cortex | 24 | 2024 | 435 | 2.290 |
Why?
|
| Glioblastoma | 6 | 2024 | 333 | 2.290 |
Why?
|
| Hippocampus | 30 | 2022 | 812 | 2.290 |
Why?
|
| Brain | 50 | 2023 | 2947 | 2.280 |
Why?
|
| Calcium Channels, N-Type | 12 | 2020 | 24 | 2.210 |
Why?
|
| Mice | 142 | 2025 | 17486 | 2.180 |
Why?
|
| Mutation | 45 | 2023 | 5774 | 2.160 |
Why?
|
| Action Potentials | 22 | 2020 | 499 | 1.940 |
Why?
|
| Electroencephalography | 47 | 2023 | 862 | 1.930 |
Why?
|
| Animals | 169 | 2025 | 33728 | 1.930 |
Why?
|
| Disease Models, Animal | 54 | 2025 | 4267 | 1.810 |
Why?
|
| Homeodomain Proteins | 8 | 2021 | 544 | 1.790 |
Why?
|
| Brain Neoplasms | 8 | 2024 | 1217 | 1.750 |
Why?
|
| Anticonvulsants | 15 | 2024 | 370 | 1.730 |
Why?
|
| Nerve Net | 7 | 2024 | 236 | 1.640 |
Why?
|
| Kv1.1 Potassium Channel | 7 | 2022 | 37 | 1.610 |
Why?
|
| Brain Stem | 3 | 2019 | 115 | 1.580 |
Why?
|
| Seizures, Febrile | 2 | 2023 | 19 | 1.540 |
Why?
|
| Ion Channels | 8 | 2017 | 188 | 1.500 |
Why?
|
| Spasms, Infantile | 5 | 2021 | 171 | 1.400 |
Why?
|
| Mice, Inbred C57BL | 48 | 2021 | 4346 | 1.330 |
Why?
|
| Synaptic Transmission | 14 | 2020 | 348 | 1.260 |
Why?
|
| Synapses | 20 | 2023 | 448 | 1.230 |
Why?
|
| Nerve Tissue Proteins | 15 | 2025 | 1117 | 1.230 |
Why?
|
| Neurogenesis | 2 | 2022 | 196 | 1.160 |
Why?
|
| Transcription Factors | 9 | 2024 | 2577 | 1.150 |
Why?
|
| Interneurons | 7 | 2016 | 139 | 1.140 |
Why?
|
| Calcium Channels, T-Type | 6 | 2020 | 12 | 1.130 |
Why?
|
| Mice, Neurologic Mutants | 29 | 2013 | 74 | 1.130 |
Why?
|
| Sodium Channels | 10 | 2019 | 109 | 1.120 |
Why?
|
| Ataxia | 11 | 2020 | 168 | 1.110 |
Why?
|
| Excitatory Postsynaptic Potentials | 9 | 2020 | 129 | 1.090 |
Why?
|
| KCNQ2 Potassium Channel | 3 | 2025 | 40 | 1.070 |
Why?
|
| NAV1.1 Voltage-Gated Sodium Channel | 4 | 2023 | 14 | 1.030 |
Why?
|
| Mice, Knockout | 34 | 2022 | 3716 | 1.000 |
Why?
|
| Mice, Transgenic | 25 | 2021 | 2391 | 0.930 |
Why?
|
| Neocortex | 4 | 2023 | 72 | 0.930 |
Why?
|
| Alzheimer Disease | 8 | 2017 | 766 | 0.900 |
Why?
|
| Cognition Disorders | 6 | 2016 | 554 | 0.890 |
Why?
|
| Potassium Channels | 9 | 2022 | 157 | 0.880 |
Why?
|
| Channelopathies | 2 | 2017 | 11 | 0.880 |
Why?
|
| Neurotransmitter Agents | 7 | 2015 | 139 | 0.870 |
Why?
|
| Purkinje Cells | 6 | 2022 | 156 | 0.860 |
Why?
|
| Presynaptic Terminals | 4 | 2015 | 76 | 0.860 |
Why?
|
| Aicardi Syndrome | 2 | 2014 | 14 | 0.850 |
Why?
|
| Brain Diseases | 4 | 2025 | 294 | 0.830 |
Why?
|
| Cortical Spreading Depression | 2 | 2021 | 8 | 0.820 |
Why?
|
| Neural Pathways | 11 | 2023 | 264 | 0.820 |
Why?
|
| Ethosuximide | 3 | 2017 | 9 | 0.760 |
Why?
|
| Heart | 3 | 2019 | 726 | 0.700 |
Why?
|
| Cerebellum | 10 | 2015 | 415 | 0.700 |
Why?
|
| Genetic Predisposition to Disease | 9 | 2016 | 3098 | 0.700 |
Why?
|
| Gene Expression Regulation | 12 | 2021 | 2533 | 0.680 |
Why?
|
| gamma-Aminobutyric Acid | 8 | 2015 | 167 | 0.680 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2020 | 65 | 0.680 |
Why?
|
| Estradiol | 3 | 2021 | 534 | 0.670 |
Why?
|
| Phenotype | 38 | 2023 | 4224 | 0.660 |
Why?
|
| Neoplasms, Experimental | 1 | 2020 | 211 | 0.650 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2020 | 125 | 0.650 |
Why?
|
| Autonomic Fibers, Preganglionic | 1 | 2019 | 5 | 0.650 |
Why?
|
| Calcium Channels, P-Type | 7 | 2013 | 9 | 0.650 |
Why?
|
| Adrenergic Agonists | 1 | 2019 | 11 | 0.650 |
Why?
|
| Apoptosis | 5 | 2020 | 1782 | 0.640 |
Why?
|
| Medulla Oblongata | 1 | 2019 | 22 | 0.640 |
Why?
|
| Periodicity | 1 | 2019 | 56 | 0.630 |
Why?
|
| Calcium | 10 | 2024 | 1095 | 0.610 |
Why?
|
| Calcium Channels, Q-Type | 6 | 2013 | 8 | 0.600 |
Why?
|
| Mossy Fibers, Hippocampal | 3 | 2005 | 8 | 0.600 |
Why?
|
| Visual Cortex | 2 | 2018 | 109 | 0.600 |
Why?
|
| Humans | 103 | 2025 | 123180 | 0.590 |
Why?
|
| Genotype | 9 | 2017 | 2548 | 0.580 |
Why?
|
| CRISPR-Cas Systems | 1 | 2020 | 251 | 0.570 |
Why?
|
| Immunity, Innate | 1 | 2020 | 372 | 0.570 |
Why?
|
| Death, Sudden, Cardiac | 2 | 2016 | 246 | 0.570 |
Why?
|
| Brain Waves | 1 | 2017 | 46 | 0.560 |
Why?
|
| Mice, Mutant Strains | 10 | 2018 | 382 | 0.560 |
Why?
|
| Patch-Clamp Techniques | 10 | 2020 | 277 | 0.550 |
Why?
|
| Glutamic Acid | 4 | 2024 | 194 | 0.550 |
Why?
|
| tau Proteins | 3 | 2015 | 189 | 0.550 |
Why?
|
| Biomedical Research | 4 | 2016 | 519 | 0.550 |
Why?
|
| Genome | 3 | 2016 | 472 | 0.540 |
Why?
|
| Arrhythmias, Cardiac | 3 | 2013 | 457 | 0.540 |
Why?
|
| Vagus Nerve | 3 | 2022 | 43 | 0.530 |
Why?
|
| KCNQ Potassium Channels | 2 | 2014 | 6 | 0.530 |
Why?
|
| Peer Review, Research | 1 | 2016 | 47 | 0.520 |
Why?
|
| Gamma Rhythm | 1 | 2015 | 12 | 0.520 |
Why?
|
| Membrane Proteins | 6 | 2023 | 1528 | 0.520 |
Why?
|
| Brain Chemistry | 4 | 2013 | 120 | 0.490 |
Why?
|
| ADAM Proteins | 1 | 2015 | 79 | 0.490 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 2 | 2016 | 232 | 0.480 |
Why?
|
| ras GTPase-Activating Proteins | 1 | 2014 | 18 | 0.470 |
Why?
|
| Prosencephalon | 1 | 2014 | 40 | 0.470 |
Why?
|
| Retinoid X Receptors | 1 | 2014 | 33 | 0.460 |
Why?
|
| RNA, Messenger | 16 | 2014 | 2820 | 0.460 |
Why?
|
| Tetrahydronaphthalenes | 1 | 2014 | 29 | 0.460 |
Why?
|
| Models, Genetic | 6 | 2014 | 767 | 0.450 |
Why?
|
| Zinc | 6 | 2011 | 128 | 0.440 |
Why?
|
| Neural Inhibition | 9 | 2014 | 105 | 0.440 |
Why?
|
| Axons | 11 | 2023 | 381 | 0.430 |
Why?
|
| Epilepsy, Generalized | 3 | 2006 | 64 | 0.430 |
Why?
|
| Membrane Potentials | 10 | 2020 | 304 | 0.420 |
Why?
|
| Cation Transport Proteins | 2 | 2011 | 97 | 0.410 |
Why?
|
| Chloride Channels | 1 | 2013 | 62 | 0.410 |
Why?
|
| Glioma | 3 | 2023 | 491 | 0.410 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2015 | 997 | 0.400 |
Why?
|
| Neuropeptide Y | 4 | 2010 | 36 | 0.400 |
Why?
|
| Carcinogenesis | 3 | 2024 | 328 | 0.400 |
Why?
|
| In Vitro Techniques | 14 | 2014 | 966 | 0.400 |
Why?
|
| Cell Movement | 1 | 2015 | 831 | 0.400 |
Why?
|
| Tumor Microenvironment | 3 | 2024 | 534 | 0.390 |
Why?
|
| Chromosome Deletion | 4 | 2010 | 638 | 0.390 |
Why?
|
| Chromosomes, Human, Pair 17 | 3 | 2006 | 371 | 0.380 |
Why?
|
| Male | 48 | 2025 | 60022 | 0.370 |
Why?
|
| Alternative Splicing | 4 | 2016 | 346 | 0.360 |
Why?
|
| Receptors, GABA-A | 5 | 2016 | 59 | 0.360 |
Why?
|
| Age of Onset | 5 | 2024 | 581 | 0.360 |
Why?
|
| Heart Arrest | 1 | 2015 | 341 | 0.360 |
Why?
|
| Syndrome | 7 | 2020 | 1114 | 0.360 |
Why?
|
| Video Recording | 5 | 2015 | 181 | 0.360 |
Why?
|
| Chromosome Mapping | 12 | 2010 | 1083 | 0.350 |
Why?
|
| Point Mutation | 4 | 2009 | 348 | 0.350 |
Why?
|
| Gene Deletion | 6 | 2020 | 793 | 0.350 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2011 | 72 | 0.340 |
Why?
|
| KCNQ1 Potassium Channel | 1 | 2009 | 11 | 0.340 |
Why?
|
| Nerve Degeneration | 1 | 2011 | 126 | 0.340 |
Why?
|
| Gene Expression Profiling | 4 | 2013 | 1683 | 0.340 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2023 | 428 | 0.320 |
Why?
|
| Molecular Sequence Data | 12 | 2013 | 3871 | 0.320 |
Why?
|
| Trinucleotide Repeats | 1 | 2009 | 109 | 0.320 |
Why?
|
| Pyramidal Cells | 7 | 2025 | 167 | 0.320 |
Why?
|
| Age Factors | 6 | 2020 | 2801 | 0.320 |
Why?
|
| Genetic Variation | 3 | 2016 | 1480 | 0.310 |
Why?
|
| Amino Acid Sequence | 10 | 2016 | 2698 | 0.310 |
Why?
|
| Exocytosis | 2 | 2006 | 64 | 0.310 |
Why?
|
| Glucagon | 1 | 2008 | 185 | 0.310 |
Why?
|
| Organ Culture Techniques | 3 | 2021 | 155 | 0.300 |
Why?
|
| Genes | 5 | 2015 | 444 | 0.300 |
Why?
|
| Spectrin | 2 | 2020 | 63 | 0.300 |
Why?
|
| DNA-Binding Proteins | 6 | 2024 | 2048 | 0.300 |
Why?
|
| Norepinephrine | 7 | 2019 | 175 | 0.300 |
Why?
|
| Female | 42 | 2025 | 65428 | 0.300 |
Why?
|
| Neuronal Plasticity | 7 | 2011 | 274 | 0.290 |
Why?
|
| Islets of Langerhans | 1 | 2008 | 173 | 0.290 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2023 | 467 | 0.290 |
Why?
|
| Central Nervous System | 5 | 2007 | 253 | 0.290 |
Why?
|
| Astrocytes | 3 | 2020 | 250 | 0.290 |
Why?
|
| In Situ Hybridization | 8 | 2005 | 473 | 0.290 |
Why?
|
| Bipolar Disorder | 2 | 2023 | 347 | 0.280 |
Why?
|
| Amyloid beta-Peptides | 4 | 2014 | 206 | 0.280 |
Why?
|
| Diagnostic Imaging | 2 | 2006 | 272 | 0.280 |
Why?
|
| Behavior, Animal | 10 | 2021 | 478 | 0.280 |
Why?
|
| Nervous System Diseases | 3 | 2019 | 370 | 0.280 |
Why?
|
| Proteins | 2 | 2005 | 1039 | 0.270 |
Why?
|
| Heterozygote | 4 | 2007 | 672 | 0.270 |
Why?
|
| Gene Expression | 8 | 2003 | 1569 | 0.270 |
Why?
|
| Long-Term Synaptic Depression | 1 | 2006 | 13 | 0.270 |
Why?
|
| Glucose | 3 | 2017 | 865 | 0.260 |
Why?
|
| Myoclonic Epilepsies, Progressive | 2 | 2022 | 13 | 0.260 |
Why?
|
| Nerve Fibers | 4 | 1995 | 71 | 0.260 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2006 | 44 | 0.260 |
Why?
|
| Animals, Newborn | 9 | 2021 | 991 | 0.260 |
Why?
|
| Dentate Gyrus | 5 | 2007 | 53 | 0.260 |
Why?
|
| Transcription, Genetic | 7 | 2015 | 1695 | 0.260 |
Why?
|
| Phenylenediamines | 2 | 2025 | 25 | 0.250 |
Why?
|
| Comorbidity | 5 | 2023 | 1498 | 0.250 |
Why?
|
| Polycyclic Compounds | 1 | 2005 | 4 | 0.250 |
Why?
|
| Epilepsy, Partial, Sensory | 1 | 2005 | 1 | 0.250 |
Why?
|
| Carbamates | 2 | 2025 | 57 | 0.250 |
Why?
|
| Brain Mapping | 1 | 2008 | 398 | 0.250 |
Why?
|
| Cerebellar Diseases | 2 | 2023 | 74 | 0.240 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2004 | 172 | 0.240 |
Why?
|
| DNA | 4 | 2013 | 1592 | 0.240 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 1996 | 187 | 0.240 |
Why?
|
| Calcium Channel Blockers | 4 | 2008 | 113 | 0.240 |
Why?
|
| Microscopy, Fluorescence | 2 | 2005 | 330 | 0.230 |
Why?
|
| Limbic System | 4 | 2002 | 22 | 0.230 |
Why?
|
| Protein Subunits | 7 | 2016 | 164 | 0.230 |
Why?
|
| Mechanistic Target of Rapamycin Complex 2 | 2 | 2023 | 28 | 0.220 |
Why?
|
| Essential Tremor | 1 | 2005 | 90 | 0.220 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2016 | 2599 | 0.220 |
Why?
|
| Histones | 2 | 2024 | 528 | 0.220 |
Why?
|
| Potassium | 6 | 2023 | 278 | 0.220 |
Why?
|
| Inhibitory Postsynaptic Potentials | 3 | 2020 | 25 | 0.220 |
Why?
|
| Insulin | 1 | 2008 | 1197 | 0.220 |
Why?
|
| Valine | 1 | 2003 | 105 | 0.210 |
Why?
|
| Glutamates | 2 | 2022 | 68 | 0.210 |
Why?
|
| Receptors, GABA | 1 | 2003 | 14 | 0.210 |
Why?
|
| Epilepsy, Benign Neonatal | 2 | 2016 | 13 | 0.210 |
Why?
|
| Chromosomes, Human, Pair 22 | 2 | 2000 | 102 | 0.210 |
Why?
|
| Ependymoma | 1 | 2024 | 133 | 0.210 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 2023 | 16 | 0.210 |
Why?
|
| Solitary Nucleus | 1 | 2022 | 2 | 0.210 |
Why?
|
| Multigene Family | 2 | 2001 | 298 | 0.210 |
Why?
|
| Nodose Ganglion | 1 | 2022 | 3 | 0.210 |
Why?
|
| Electric Stimulation | 7 | 2014 | 315 | 0.210 |
Why?
|
| Fructose | 1 | 2003 | 62 | 0.210 |
Why?
|
| Biology | 1 | 2003 | 29 | 0.210 |
Why?
|
| Electrophysiology | 9 | 2011 | 268 | 0.210 |
Why?
|
| Glucose Transporter Type 1 | 2 | 2017 | 24 | 0.210 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2001 | 118 | 0.210 |
Why?
|
| Genomics | 4 | 2019 | 1477 | 0.200 |
Why?
|
| Carrier Proteins | 3 | 2020 | 1021 | 0.200 |
Why?
|
| Calcium Signaling | 1 | 2024 | 241 | 0.200 |
Why?
|
| Central Nervous System Diseases | 2 | 2003 | 105 | 0.200 |
Why?
|
| Bridged Bicyclo Compounds | 1 | 2021 | 3 | 0.200 |
Why?
|
| Mental Disorders | 1 | 2009 | 827 | 0.200 |
Why?
|
| Ranvier's Nodes | 2 | 2017 | 73 | 0.200 |
Why?
|
| Gene Duplication | 2 | 2003 | 358 | 0.190 |
Why?
|
| Cell Death | 4 | 2011 | 242 | 0.190 |
Why?
|
| Disease Progression | 4 | 2024 | 2024 | 0.190 |
Why?
|
| Anilides | 1 | 2021 | 48 | 0.190 |
Why?
|
| Genes, Immediate-Early | 2 | 1998 | 5 | 0.190 |
Why?
|
| Cortical Synchronization | 3 | 1997 | 11 | 0.190 |
Why?
|
| GAP-43 Protein | 1 | 2001 | 5 | 0.190 |
Why?
|
| Autistic Disorder | 3 | 2015 | 346 | 0.190 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2002 | 243 | 0.190 |
Why?
|
| Epilepsies, Partial | 4 | 2006 | 91 | 0.190 |
Why?
|
| Intellectual Disability | 3 | 2021 | 1043 | 0.190 |
Why?
|
| Electrocardiography | 7 | 2014 | 961 | 0.190 |
Why?
|
| Entorhinal Cortex | 1 | 2001 | 28 | 0.190 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2001 | 59 | 0.180 |
Why?
|
| Mice, 129 Strain | 3 | 2020 | 98 | 0.180 |
Why?
|
| Excitatory Amino Acid Antagonists | 4 | 2008 | 94 | 0.180 |
Why?
|
| Epilepsy, Rolandic | 1 | 2000 | 6 | 0.180 |
Why?
|
| Abnormalities, Multiple | 2 | 2007 | 965 | 0.180 |
Why?
|
| Aging | 6 | 2015 | 1172 | 0.180 |
Why?
|
| Chromosomes | 3 | 2003 | 198 | 0.180 |
Why?
|
| Myelin Sheath | 4 | 1998 | 132 | 0.180 |
Why?
|
| Memory | 3 | 2014 | 360 | 0.180 |
Why?
|
| Cells, Cultured | 8 | 2020 | 3049 | 0.180 |
Why?
|
| Voltage-Gated Sodium Channels | 1 | 2020 | 12 | 0.180 |
Why?
|
| Neoplasm Proteins | 1 | 2004 | 670 | 0.170 |
Why?
|
| Thalamic Nuclei | 2 | 2020 | 16 | 0.170 |
Why?
|
| Transcriptome | 2 | 2024 | 909 | 0.170 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 4 | 2011 | 306 | 0.170 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2024 | 1873 | 0.170 |
Why?
|
| Neurodegenerative Diseases | 1 | 2023 | 253 | 0.170 |
Why?
|
| Gene Targeting | 3 | 2000 | 179 | 0.170 |
Why?
|
| Axon Initial Segment | 1 | 2020 | 21 | 0.170 |
Why?
|
| Mutation, Missense | 3 | 2016 | 847 | 0.170 |
Why?
|
| Ankyrins | 2 | 2020 | 99 | 0.170 |
Why?
|
| Evolution, Molecular | 2 | 2001 | 672 | 0.170 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2020 | 74 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-jun | 2 | 1998 | 43 | 0.170 |
Why?
|
| Angelman Syndrome | 3 | 2010 | 69 | 0.160 |
Why?
|
| Exons | 4 | 2016 | 795 | 0.160 |
Why?
|
| Blotting, Western | 4 | 2013 | 1102 | 0.160 |
Why?
|
| Synaptic Potentials | 1 | 2019 | 12 | 0.160 |
Why?
|
| Cerebellar Ataxia | 1 | 2000 | 65 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-fos | 2 | 1998 | 64 | 0.160 |
Why?
|
| Microglia | 1 | 2020 | 95 | 0.160 |
Why?
|
| Genetic Testing | 3 | 2012 | 997 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 1999 | 150 | 0.160 |
Why?
|
| Systems Biology | 1 | 2019 | 58 | 0.160 |
Why?
|
| Rett Syndrome | 3 | 2010 | 289 | 0.160 |
Why?
|
| Protein Isoforms | 4 | 2016 | 409 | 0.160 |
Why?
|
| Sleep | 2 | 2023 | 348 | 0.160 |
Why?
|
| Long-Term Potentiation | 4 | 2011 | 163 | 0.160 |
Why?
|
| Immediate-Early Proteins | 1 | 1998 | 58 | 0.150 |
Why?
|
| Polymorphism, Genetic | 3 | 2002 | 810 | 0.150 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2015 | 1294 | 0.150 |
Why?
|
| Estrogens | 1 | 2021 | 507 | 0.150 |
Why?
|
| Epilepsies, Myoclonic | 2 | 2013 | 24 | 0.150 |
Why?
|
| Microfilament Proteins | 1 | 2020 | 277 | 0.150 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2016 | 657 | 0.150 |
Why?
|
| Epinephrine | 1 | 2019 | 174 | 0.150 |
Why?
|
| Animals, Genetically Modified | 1 | 1999 | 316 | 0.150 |
Why?
|
| Locus Coeruleus | 4 | 1991 | 22 | 0.150 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2019 | 269 | 0.150 |
Why?
|
| Cell Survival | 1 | 2020 | 803 | 0.150 |
Why?
|
| Epilepsy, Temporal Lobe | 2 | 2011 | 84 | 0.140 |
Why?
|
| Tissue Distribution | 6 | 2004 | 382 | 0.140 |
Why?
|
| Potassium Channels, Voltage-Gated | 3 | 2009 | 58 | 0.140 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2017 | 39 | 0.140 |
Why?
|
| Advisory Committees | 1 | 2017 | 148 | 0.140 |
Why?
|
| Carbohydrate Metabolism, Inborn Errors | 1 | 2017 | 36 | 0.140 |
Why?
|
| Sequence Analysis, DNA | 3 | 2013 | 1760 | 0.140 |
Why?
|
| Cytoskeleton | 1 | 2017 | 178 | 0.140 |
Why?
|
| Microvessels | 1 | 2017 | 56 | 0.140 |
Why?
|
| Rats | 7 | 2008 | 3631 | 0.140 |
Why?
|
| Reaction Time | 2 | 2016 | 169 | 0.130 |
Why?
|
| Receptors, Neurotensin | 1 | 2016 | 4 | 0.130 |
Why?
|
| Motor Disorders | 1 | 2016 | 5 | 0.130 |
Why?
|
| Mutant Proteins | 1 | 2016 | 112 | 0.130 |
Why?
|
| Infant, Newborn | 5 | 2024 | 8089 | 0.130 |
Why?
|
| Beta Rhythm | 1 | 2015 | 20 | 0.130 |
Why?
|
| Mice, Inbred C3H | 3 | 2004 | 118 | 0.130 |
Why?
|
| Cysteine Endopeptidases | 2 | 2014 | 114 | 0.130 |
Why?
|
| Cloning, Molecular | 5 | 2001 | 893 | 0.130 |
Why?
|
| Luminescent Proteins | 1 | 2016 | 157 | 0.130 |
Why?
|
| RNA Splicing | 2 | 2012 | 223 | 0.120 |
Why?
|
| Motor Activity | 6 | 2020 | 520 | 0.120 |
Why?
|
| Transplants | 1 | 2015 | 36 | 0.120 |
Why?
|
| Amyloid beta-Protein Precursor | 2 | 2014 | 121 | 0.120 |
Why?
|
| Neuropeptides | 3 | 2002 | 114 | 0.120 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 3 | 2011 | 148 | 0.120 |
Why?
|
| Base Sequence | 7 | 2001 | 3093 | 0.120 |
Why?
|
| Genes, Dominant | 3 | 2005 | 247 | 0.120 |
Why?
|
| Hormones | 1 | 2015 | 190 | 0.120 |
Why?
|
| 2-Amino-5-phosphonovalerate | 2 | 2007 | 14 | 0.120 |
Why?
|
| Excitatory Amino Acid Agonists | 3 | 2011 | 18 | 0.120 |
Why?
|
| CA3 Region, Hippocampal | 1 | 2014 | 15 | 0.120 |
Why?
|
| Myocardium | 1 | 1999 | 982 | 0.110 |
Why?
|
| Precision Medicine | 1 | 2017 | 313 | 0.110 |
Why?
|
| GABAergic Neurons | 1 | 2014 | 54 | 0.110 |
Why?
|
| Spasm | 1 | 2014 | 48 | 0.110 |
Why?
|
| Genetic Therapy | 2 | 2015 | 673 | 0.110 |
Why?
|
| Cathepsins | 2 | 2003 | 21 | 0.110 |
Why?
|
| Neural Conduction | 1 | 1994 | 92 | 0.110 |
Why?
|
| Immunohistochemistry | 5 | 2015 | 1684 | 0.110 |
Why?
|
| Drug Evaluation | 1 | 2013 | 111 | 0.110 |
Why?
|
| Crosses, Genetic | 6 | 2006 | 161 | 0.110 |
Why?
|
| Drugs, Investigational | 1 | 2013 | 22 | 0.110 |
Why?
|
| Estrogen Receptor beta | 1 | 2014 | 78 | 0.110 |
Why?
|
| Baclofen | 2 | 2006 | 39 | 0.110 |
Why?
|
| Periodicals as Topic | 1 | 2016 | 195 | 0.110 |
Why?
|
| Electrophoresis | 1 | 2013 | 47 | 0.110 |
Why?
|
| Random Allocation | 1 | 2014 | 423 | 0.110 |
Why?
|
| Gene Knock-In Techniques | 2 | 2014 | 122 | 0.110 |
Why?
|
| Dried Blood Spot Testing | 1 | 2013 | 22 | 0.110 |
Why?
|
| Homeostasis | 2 | 2016 | 681 | 0.110 |
Why?
|
| Signal Transduction | 4 | 2023 | 4500 | 0.110 |
Why?
|
| Heart Atria | 1 | 2015 | 310 | 0.100 |
Why?
|
| Propranolol | 2 | 2010 | 128 | 0.100 |
Why?
|
| Software | 1 | 2017 | 677 | 0.100 |
Why?
|
| ELAV Proteins | 1 | 2012 | 13 | 0.100 |
Why?
|
| Drosophila | 2 | 2013 | 766 | 0.100 |
Why?
|
| Mosaicism | 2 | 2006 | 240 | 0.100 |
Why?
|
| Unverricht-Lundborg Syndrome | 2 | 2003 | 2 | 0.100 |
Why?
|
| Temporal Lobe | 1 | 2013 | 116 | 0.100 |
Why?
|
| Carnitine Acyltransferases | 1 | 2012 | 6 | 0.100 |
Why?
|
| Adenosine | 2 | 2006 | 126 | 0.100 |
Why?
|
| Kainic Acid | 2 | 2011 | 27 | 0.100 |
Why?
|
| Astrocytoma | 1 | 2013 | 102 | 0.100 |
Why?
|
| 6-Cyano-7-nitroquinoxaline-2,3-dione | 2 | 2003 | 15 | 0.100 |
Why?
|
| Voltage-Gated Sodium Channel beta-1 Subunit | 2 | 2008 | 2 | 0.100 |
Why?
|
| Drug Discovery | 1 | 2013 | 171 | 0.100 |
Why?
|
| Administration, Oral | 1 | 2014 | 671 | 0.100 |
Why?
|
| Pyramidal Tracts | 4 | 1993 | 36 | 0.100 |
Why?
|
| RNA-Binding Proteins | 2 | 2013 | 573 | 0.100 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2004 | 214 | 0.100 |
Why?
|
| eIF-2 Kinase | 1 | 2011 | 37 | 0.100 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2012 | 150 | 0.100 |
Why?
|
| Positron-Emission Tomography | 2 | 2017 | 287 | 0.100 |
Why?
|
| Myelin Basic Protein | 1 | 1991 | 69 | 0.100 |
Why?
|
| Ethics, Medical | 2 | 2011 | 396 | 0.100 |
Why?
|
| Muscular Diseases | 1 | 2012 | 102 | 0.090 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2012 | 149 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 1 | 2011 | 6 | 0.090 |
Why?
|
| Demyelinating Diseases | 1 | 1991 | 67 | 0.090 |
Why?
|
| Fluoresceins | 1 | 2011 | 35 | 0.090 |
Why?
|
| Epistasis, Genetic | 1 | 2011 | 91 | 0.090 |
Why?
|
| Hypoglycemia | 2 | 2012 | 191 | 0.090 |
Why?
|
| Dyskinesias | 1 | 2011 | 19 | 0.090 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 2 | 2023 | 162 | 0.090 |
Why?
|
| Organic Chemicals | 1 | 2011 | 59 | 0.090 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 815 | 0.090 |
Why?
|
| Stereotypic Movement Disorder | 1 | 2010 | 13 | 0.090 |
Why?
|
| Vocalization, Animal | 1 | 2010 | 17 | 0.090 |
Why?
|
| Ether-A-Go-Go Potassium Channels | 1 | 2010 | 5 | 0.090 |
Why?
|
| NAV1.5 Voltage-Gated Sodium Channel | 2 | 2002 | 38 | 0.090 |
Why?
|
| Parasympatholytics | 1 | 2010 | 7 | 0.090 |
Why?
|
| Atropine | 1 | 2010 | 30 | 0.090 |
Why?
|
| Ventricular Premature Complexes | 1 | 2010 | 10 | 0.090 |
Why?
|
| Estrogen Receptor alpha | 1 | 2014 | 450 | 0.090 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2011 | 133 | 0.090 |
Why?
|
| Antigens, Neoplasm | 1 | 2013 | 390 | 0.090 |
Why?
|
| Ion Channel Gating | 3 | 2016 | 123 | 0.090 |
Why?
|
| Trans-Activators | 2 | 2007 | 799 | 0.090 |
Why?
|
| Longevity | 1 | 2011 | 138 | 0.090 |
Why?
|
| Bradycardia | 1 | 2010 | 59 | 0.090 |
Why?
|
| Homozygote | 5 | 2010 | 533 | 0.080 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2012 | 280 | 0.080 |
Why?
|
| Nuclear Receptor Coactivator 3 | 1 | 2012 | 345 | 0.080 |
Why?
|
| Atrioventricular Block | 1 | 2010 | 39 | 0.080 |
Why?
|
| Autoradiography | 3 | 1999 | 71 | 0.080 |
Why?
|
| Information Dissemination | 1 | 2011 | 187 | 0.080 |
Why?
|
| Green Fluorescent Proteins | 1 | 2011 | 394 | 0.080 |
Why?
|
| Interferon-gamma | 1 | 2011 | 511 | 0.080 |
Why?
|
| DNA Transposable Elements | 2 | 2003 | 177 | 0.080 |
Why?
|
| Recombinant Proteins | 3 | 2016 | 1390 | 0.080 |
Why?
|
| Cytoskeletal Proteins | 1 | 2010 | 270 | 0.080 |
Why?
|
| Membrane Transport Proteins | 2 | 2010 | 177 | 0.080 |
Why?
|
| Cell Differentiation | 2 | 2015 | 1916 | 0.080 |
Why?
|
| RNA Splice Sites | 1 | 2009 | 87 | 0.080 |
Why?
|
| Genetic Linkage | 4 | 2002 | 454 | 0.080 |
Why?
|
| Cognition | 1 | 2014 | 735 | 0.080 |
Why?
|
| Organ Specificity | 3 | 1999 | 423 | 0.080 |
Why?
|
| Heart Rate | 2 | 2011 | 585 | 0.080 |
Why?
|
| Oscillometry | 1 | 2008 | 15 | 0.080 |
Why?
|
| Repressor Proteins | 2 | 2004 | 811 | 0.080 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2010 | 218 | 0.080 |
Why?
|
| KCNQ3 Potassium Channel | 1 | 2008 | 19 | 0.080 |
Why?
|
| Computer Simulation | 1 | 2011 | 637 | 0.080 |
Why?
|
| Amino Acid Transport Systems, Acidic | 1 | 2008 | 1 | 0.080 |
Why?
|
| Somatosensory Cortex | 2 | 1978 | 48 | 0.080 |
Why?
|
| Atrial Fibrillation | 1 | 2015 | 623 | 0.080 |
Why?
|
| Child | 9 | 2022 | 24208 | 0.080 |
Why?
|
| Kindling, Neurologic | 1 | 2008 | 13 | 0.080 |
Why?
|
| omega-Agatoxin IVA | 1 | 2007 | 4 | 0.070 |
Why?
|
| Phylogeny | 2 | 2001 | 685 | 0.070 |
Why?
|
| Glucose Tolerance Test | 1 | 2008 | 204 | 0.070 |
Why?
|
| Biomarkers | 2 | 2015 | 2943 | 0.070 |
Why?
|
| Informed Consent | 2 | 2011 | 342 | 0.070 |
Why?
|
| Potassium Chloride | 1 | 2007 | 54 | 0.070 |
Why?
|
| Parvalbumins | 2 | 2016 | 33 | 0.070 |
Why?
|
| Penicillin G | 2 | 1977 | 19 | 0.070 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2004 | 123 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 2 | 2012 | 1015 | 0.070 |
Why?
|
| Protein Domains | 2 | 2020 | 235 | 0.070 |
Why?
|
| Mothers | 1 | 2010 | 350 | 0.070 |
Why?
|
| Depression | 1 | 2015 | 1225 | 0.070 |
Why?
|
| Reflex, Startle | 3 | 2010 | 32 | 0.070 |
Why?
|
| Peptides | 2 | 2021 | 796 | 0.070 |
Why?
|
| Models, Neurological | 2 | 2014 | 204 | 0.070 |
Why?
|
| Cell Line, Tumor | 2 | 2024 | 3279 | 0.070 |
Why?
|
| Congresses as Topic | 1 | 2008 | 167 | 0.070 |
Why?
|
| DNA Fingerprinting | 1 | 2006 | 108 | 0.070 |
Why?
|
| Long QT Syndrome | 1 | 2007 | 86 | 0.070 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2008 | 141 | 0.070 |
Why?
|
| Down-Regulation | 1 | 2008 | 697 | 0.070 |
Why?
|
| Amino Acid Transport System X-AG | 2 | 1996 | 6 | 0.070 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 2 | 2023 | 80 | 0.070 |
Why?
|
| Psychomotor Performance | 1 | 2007 | 188 | 0.070 |
Why?
|
| Adult | 7 | 2013 | 29039 | 0.060 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channels | 1 | 2005 | 23 | 0.060 |
Why?
|
| Dementia | 1 | 2011 | 448 | 0.060 |
Why?
|
| RNA Probes | 1 | 2005 | 30 | 0.060 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2005 | 554 | 0.060 |
Why?
|
| NIH 3T3 Cells | 1 | 2005 | 92 | 0.060 |
Why?
|
| Child, Preschool | 6 | 2013 | 13862 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2017 | 3518 | 0.060 |
Why?
|
| Corpus Callosum | 2 | 2023 | 98 | 0.060 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2004 | 15 | 0.060 |
Why?
|
| Ribonucleases | 1 | 2004 | 54 | 0.060 |
Why?
|
| Gene Frequency | 1 | 2006 | 715 | 0.060 |
Why?
|
| Glutamate Decarboxylase | 2 | 2010 | 36 | 0.060 |
Why?
|
| Time Factors | 5 | 2004 | 6201 | 0.060 |
Why?
|
| Serotonergic Neurons | 1 | 2024 | 21 | 0.060 |
Why?
|
| Movement Disorders | 2 | 2004 | 221 | 0.060 |
Why?
|
| Synaptosomal-Associated Protein 25 | 1 | 2004 | 11 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 3 | 2013 | 1586 | 0.060 |
Why?
|
| Cell Count | 3 | 2005 | 247 | 0.060 |
Why?
|
| Biological Clocks | 1 | 2004 | 28 | 0.060 |
Why?
|
| Subcellular Fractions | 2 | 2013 | 98 | 0.060 |
Why?
|
| Receptors, LDL | 1 | 2004 | 88 | 0.060 |
Why?
|
| Adolescent | 6 | 2016 | 19087 | 0.060 |
Why?
|
| Acoustic Stimulation | 3 | 2014 | 87 | 0.060 |
Why?
|
| Models, Animal | 1 | 2006 | 465 | 0.060 |
Why?
|
| Chlorides | 2 | 2014 | 104 | 0.060 |
Why?
|
| Up-Regulation | 2 | 2004 | 868 | 0.060 |
Why?
|
| Cathepsin B | 1 | 2003 | 10 | 0.060 |
Why?
|
| Mice, Inbred Strains | 4 | 2000 | 310 | 0.060 |
Why?
|
| Electrodes, Implanted | 1 | 2004 | 162 | 0.050 |
Why?
|
| Cohort Studies | 1 | 2013 | 4709 | 0.050 |
Why?
|
| Cryoelectron Microscopy | 1 | 2025 | 212 | 0.050 |
Why?
|
| Genes, Intracisternal A-Particle | 1 | 2003 | 1 | 0.050 |
Why?
|
| Cystatins | 2 | 2003 | 8 | 0.050 |
Why?
|
| Hermanski-Pudlak Syndrome | 1 | 2003 | 7 | 0.050 |
Why?
|
| Infant | 4 | 2024 | 12323 | 0.050 |
Why?
|
| WW Domain-Containing Oxidoreductase | 1 | 2023 | 4 | 0.050 |
Why?
|
| Serotonin | 1 | 2024 | 222 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2006 | 1013 | 0.050 |
Why?
|
| Models, Biological | 1 | 2008 | 1442 | 0.050 |
Why?
|
| Cell Line | 3 | 2010 | 2776 | 0.050 |
Why?
|
| Ganglia, Autonomic | 1 | 2022 | 4 | 0.050 |
Why?
|
| Urethane | 1 | 2022 | 5 | 0.050 |
Why?
|
| Transfection | 1 | 2005 | 1068 | 0.050 |
Why?
|
| Technology, Pharmaceutical | 1 | 2002 | 20 | 0.050 |
Why?
|
| Drug Interactions | 1 | 2003 | 254 | 0.050 |
Why?
|
| Quality Control | 2 | 2013 | 119 | 0.050 |
Why?
|
| Reference Values | 3 | 2000 | 696 | 0.050 |
Why?
|
| Immunoglobulins | 1 | 2023 | 168 | 0.050 |
Why?
|
| Genetic Heterogeneity | 1 | 2003 | 123 | 0.050 |
Why?
|
| Molecular Targeted Therapy | 1 | 2024 | 350 | 0.050 |
Why?
|
| Receptors, AMPA | 2 | 2010 | 49 | 0.050 |
Why?
|
| Choristoma | 1 | 2002 | 49 | 0.050 |
Why?
|
| 3' Untranslated Regions | 2 | 2013 | 165 | 0.050 |
Why?
|
| Embryo, Mammalian | 3 | 2006 | 452 | 0.050 |
Why?
|
| Pedigree | 3 | 2000 | 1582 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2011 | 3332 | 0.050 |
Why?
|
| Haplotypes | 2 | 2002 | 519 | 0.050 |
Why?
|
| DNA Primers | 2 | 2000 | 661 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2003 | 1683 | 0.050 |
Why?
|
| Patient Care Team | 1 | 2006 | 547 | 0.050 |
Why?
|
| Perforant Pathway | 1 | 2001 | 13 | 0.050 |
Why?
|
| Integrases | 1 | 2022 | 161 | 0.050 |
Why?
|
| Coculture Techniques | 2 | 2017 | 234 | 0.050 |
Why?
|
| Catecholamines | 1 | 1981 | 56 | 0.050 |
Why?
|
| DNA Damage | 1 | 2004 | 507 | 0.050 |
Why?
|
| Gene Transfer Techniques | 1 | 2003 | 355 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2001 | 139 | 0.050 |
Why?
|
| Early Medical Intervention | 1 | 2021 | 29 | 0.050 |
Why?
|
| Chromatin | 1 | 2024 | 552 | 0.050 |
Why?
|
| Muscle, Skeletal | 2 | 2012 | 936 | 0.050 |
Why?
|
| Alleles | 3 | 2001 | 1607 | 0.050 |
Why?
|
| Convulsants | 2 | 2010 | 21 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 2014 | 1011 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 2003 | 469 | 0.040 |
Why?
|
| Rotarod Performance Test | 1 | 2020 | 14 | 0.040 |
Why?
|
| Respiration | 2 | 2011 | 123 | 0.040 |
Why?
|
| Evoked Potentials | 5 | 1978 | 133 | 0.040 |
Why?
|
| omega-Conotoxins | 1 | 2000 | 3 | 0.040 |
Why?
|
| omega-Conotoxin GVIA | 1 | 2000 | 7 | 0.040 |
Why?
|
| GABA Agonists | 1 | 2000 | 15 | 0.040 |
Why?
|
| Cell Membrane | 3 | 2005 | 459 | 0.040 |
Why?
|
| Rapamycin-Insensitive Companion of mTOR Protein | 1 | 2019 | 5 | 0.040 |
Why?
|
| Physical Chromosome Mapping | 1 | 1999 | 56 | 0.040 |
Why?
|
| Lod Score | 1 | 2000 | 120 | 0.040 |
Why?
|
| Expressed Sequence Tags | 1 | 1999 | 78 | 0.040 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2023 | 619 | 0.040 |
Why?
|
| Neurology | 1 | 2001 | 108 | 0.040 |
Why?
|
| Fluorescent Dyes | 1 | 2001 | 260 | 0.040 |
Why?
|
| Drug Design | 1 | 2001 | 147 | 0.040 |
Why?
|
| Sulfur Radioisotopes | 1 | 1999 | 9 | 0.040 |
Why?
|
| Glypicans | 1 | 2020 | 39 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2024 | 667 | 0.040 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2000 | 367 | 0.040 |
Why?
|
| Stereotyped Behavior | 1 | 1979 | 37 | 0.040 |
Why?
|
| Oligonucleotide Probes | 1 | 1999 | 85 | 0.040 |
Why?
|
| Isomerism | 1 | 1999 | 31 | 0.040 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2019 | 74 | 0.040 |
Why?
|
| Neurobiology | 1 | 2019 | 25 | 0.040 |
Why?
|
| Behavior | 1 | 1979 | 75 | 0.040 |
Why?
|
| Electric Conductivity | 1 | 1999 | 89 | 0.040 |
Why?
|
| Microsatellite Repeats | 1 | 2000 | 219 | 0.040 |
Why?
|
| Biological Transport | 2 | 1998 | 347 | 0.040 |
Why?
|
| Refractory Period, Electrophysiological | 1 | 1998 | 9 | 0.040 |
Why?
|
| Calbindin 1 | 1 | 1998 | 3 | 0.040 |
Why?
|
| Calbindins | 1 | 1998 | 17 | 0.040 |
Why?
|
| Shaker Superfamily of Potassium Channels | 1 | 1999 | 27 | 0.040 |
Why?
|
| S100 Calcium Binding Protein G | 1 | 1998 | 23 | 0.040 |
Why?
|
| Calcium Channels, L-Type | 1 | 1999 | 53 | 0.040 |
Why?
|
| Genes, Recessive | 4 | 2001 | 176 | 0.040 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 1998 | 39 | 0.040 |
Why?
|
| Platelet Storage Pool Deficiency | 1 | 1998 | 2 | 0.040 |
Why?
|
| Ligases | 1 | 1998 | 46 | 0.040 |
Why?
|
| Early Growth Response Protein 1 | 1 | 1998 | 38 | 0.040 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 1999 | 87 | 0.040 |
Why?
|
| Loss of Function Mutation | 1 | 2019 | 142 | 0.040 |
Why?
|
| Mutagenesis | 1 | 2000 | 347 | 0.040 |
Why?
|
| Neuropil | 1 | 2018 | 10 | 0.040 |
Why?
|
| Melanocytes | 1 | 1998 | 47 | 0.040 |
Why?
|
| Zinc Fingers | 1 | 1998 | 114 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 1999 | 623 | 0.040 |
Why?
|
| Synaptic Vesicles | 1 | 1998 | 64 | 0.040 |
Why?
|
| Endosomes | 1 | 1998 | 67 | 0.040 |
Why?
|
| DNA Copy Number Variations | 2 | 2013 | 940 | 0.040 |
Why?
|
| Blindness | 1 | 1978 | 71 | 0.040 |
Why?
|
| Electrocorticography | 1 | 2018 | 59 | 0.040 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2000 | 256 | 0.040 |
Why?
|
| Cytoplasm | 1 | 1998 | 289 | 0.040 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 1 | 1997 | 17 | 0.040 |
Why?
|
| Sodium-Hydrogen Exchangers | 1 | 1997 | 41 | 0.040 |
Why?
|
| Foramen Ovale | 1 | 2017 | 3 | 0.040 |
Why?
|
| Darkness | 2 | 2010 | 29 | 0.040 |
Why?
|
| Neuroglia | 2 | 1996 | 193 | 0.040 |
Why?
|
| COS Cells | 1 | 2017 | 273 | 0.040 |
Why?
|
| Drug Resistance | 2 | 2012 | 256 | 0.040 |
Why?
|
| Synaptic Membranes | 2 | 1994 | 23 | 0.040 |
Why?
|
| Neuromuscular Junction | 1 | 1977 | 92 | 0.040 |
Why?
|
| Oxidoreductases Acting on CH-NH Group Donors | 1 | 2017 | 26 | 0.040 |
Why?
|
| Memory Consolidation | 1 | 2017 | 12 | 0.040 |
Why?
|
| Isoenzymes | 1 | 1997 | 223 | 0.040 |
Why?
|
| Molecular Weight | 2 | 2013 | 392 | 0.040 |
Why?
|
| Electrodes | 1 | 2017 | 97 | 0.040 |
Why?
|
| Exploratory Behavior | 2 | 2010 | 52 | 0.040 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2017 | 39 | 0.030 |
Why?
|
| Autoantigens | 1 | 1997 | 120 | 0.030 |
Why?
|
| Genomic Imprinting | 1 | 1997 | 123 | 0.030 |
Why?
|
| Diencephalon | 1 | 1996 | 10 | 0.030 |
Why?
|
| Receptors, Neurotransmitter | 1 | 1996 | 21 | 0.030 |
Why?
|
| Blood-Brain Barrier | 1 | 2017 | 141 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2023 | 2307 | 0.030 |
Why?
|
| Basal Ganglia | 1 | 1996 | 54 | 0.030 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2021 | 475 | 0.030 |
Why?
|
| Proteomics | 1 | 2019 | 479 | 0.030 |
Why?
|
| Blood Platelets | 1 | 1998 | 333 | 0.030 |
Why?
|
| Solubility | 1 | 1995 | 131 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2017 | 211 | 0.030 |
Why?
|
| Brain Ischemia | 1 | 1998 | 251 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2016 | 389 | 0.030 |
Why?
|
| Translocation, Genetic | 1 | 1997 | 351 | 0.030 |
Why?
|
| Sympathetic Nervous System | 2 | 1986 | 62 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2015 | 312 | 0.030 |
Why?
|
| Cats | 4 | 1978 | 117 | 0.030 |
Why?
|
| DNA, Complementary | 1 | 1995 | 463 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 1997 | 1002 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2017 | 803 | 0.030 |
Why?
|
| Potassium Channel Blockers | 1 | 2014 | 83 | 0.030 |
Why?
|
| Entropy | 1 | 2014 | 26 | 0.030 |
Why?
|
| Suppression, Genetic | 1 | 2014 | 43 | 0.030 |
Why?
|
| Presenilin-1 | 1 | 2014 | 52 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2014 | 198 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 1998 | 715 | 0.030 |
Why?
|
| Mortality | 1 | 2015 | 230 | 0.030 |
Why?
|
| Urodela | 1 | 1993 | 19 | 0.030 |
Why?
|
| Species Specificity | 2 | 2011 | 549 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2016 | 740 | 0.030 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2014 | 62 | 0.030 |
Why?
|
| DNA Mutational Analysis | 2 | 2010 | 793 | 0.030 |
Why?
|
| Annexin A6 | 1 | 1993 | 1 | 0.030 |
Why?
|
| Autopsy | 1 | 2013 | 110 | 0.030 |
Why?
|
| Confusion | 1 | 2013 | 16 | 0.030 |
Why?
|
| Drug Industry | 1 | 2013 | 46 | 0.030 |
Why?
|
| Aphasia | 1 | 2013 | 14 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2017 | 921 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 1995 | 481 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 1993 | 391 | 0.030 |
Why?
|
| Retinal Rod Photoreceptor Cells | 1 | 1993 | 84 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 514 | 0.030 |
Why?
|
| Research Support as Topic | 1 | 2013 | 64 | 0.030 |
Why?
|
| Videotape Recording | 1 | 2013 | 57 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2016 | 1070 | 0.030 |
Why?
|
| Fluorescence | 1 | 2013 | 93 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2010 | 353 | 0.030 |
Why?
|
| Muscles | 1 | 1993 | 288 | 0.030 |
Why?
|
| Aged | 3 | 2017 | 19072 | 0.030 |
Why?
|
| Transgenes | 1 | 2014 | 334 | 0.030 |
Why?
|
| Survival Rate | 2 | 2010 | 1995 | 0.030 |
Why?
|
| Craniofacial Abnormalities | 2 | 2007 | 244 | 0.030 |
Why?
|
| Glutaminase | 1 | 2012 | 14 | 0.030 |
Why?
|
| Ketosis | 1 | 2012 | 15 | 0.030 |
Why?
|
| Brain Injuries | 1 | 1998 | 734 | 0.020 |
Why?
|
| Consent Forms | 1 | 2011 | 24 | 0.020 |
Why?
|
| Hyperammonemia | 1 | 2012 | 60 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2012 | 231 | 0.020 |
Why?
|
| Cystatin B | 2 | 2003 | 2 | 0.020 |
Why?
|
| Saxitoxin | 1 | 1991 | 2 | 0.020 |
Why?
|
| Glyoxylates | 1 | 1991 | 4 | 0.020 |
Why?
|
| Oxidopamine | 1 | 1991 | 15 | 0.020 |
Why?
|
| Methoxyhydroxyphenylglycol | 1 | 1991 | 35 | 0.020 |
Why?
|
| Specimen Handling | 1 | 2012 | 142 | 0.020 |
Why?
|
| Respiratory Center | 1 | 2011 | 10 | 0.020 |
Why?
|
| National Institute of Neurological Disorders and Stroke (U.S.) | 1 | 2011 | 8 | 0.020 |
Why?
|
| Dopamine | 2 | 2004 | 275 | 0.020 |
Why?
|
| Histocytochemistry | 1 | 1991 | 98 | 0.020 |
Why?
|
| Genetic Privacy | 1 | 2011 | 40 | 0.020 |
Why?
|
| Neonatal Screening | 1 | 2013 | 184 | 0.020 |
Why?
|
| Rhombencephalon | 1 | 2011 | 45 | 0.020 |
Why?
|
| Antibodies | 1 | 2012 | 370 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2011 | 235 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2012 | 444 | 0.020 |
Why?
|
| Middle Aged | 3 | 2017 | 25980 | 0.020 |
Why?
|
| Motor Skills | 1 | 2011 | 83 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2013 | 574 | 0.020 |
Why?
|
| Vesicular Inhibitory Amino Acid Transport Proteins | 1 | 2010 | 17 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2011 | 132 | 0.020 |
Why?
|
| Oligodendroglia | 1 | 1991 | 84 | 0.020 |
Why?
|
| Psychomotor Disorders | 1 | 2010 | 28 | 0.020 |
Why?
|
| Picrotoxin | 1 | 1990 | 14 | 0.020 |
Why?
|
| Pentylenetetrazole | 1 | 2010 | 29 | 0.020 |
Why?
|
| Compulsive Behavior | 1 | 2010 | 40 | 0.020 |
Why?
|
| Ultrasonics | 1 | 2010 | 37 | 0.020 |
Why?
|
| Risk Factors | 2 | 2015 | 10000 | 0.020 |
Why?
|
| Xenopus | 1 | 2010 | 107 | 0.020 |
Why?
|
| Isoproterenol | 1 | 1990 | 105 | 0.020 |
Why?
|
| Myocytes, Cardiac | 1 | 2015 | 617 | 0.020 |
Why?
|
| Sodium | 2 | 2004 | 290 | 0.020 |
Why?
|
| Self-Injurious Behavior | 1 | 2010 | 64 | 0.020 |
Why?
|
| Fatty Acids | 1 | 2012 | 338 | 0.020 |
Why?
|
| Theta Rhythm | 1 | 1989 | 25 | 0.020 |
Why?
|
| Organ Size | 2 | 2003 | 412 | 0.020 |
Why?
|
| Hypoxia | 1 | 2011 | 245 | 0.020 |
Why?
|
| Adenosine Triphosphatases | 1 | 2010 | 208 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2016 | 3260 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2016 | 1650 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2012 | 352 | 0.020 |
Why?
|
| Differential Threshold | 2 | 2000 | 11 | 0.020 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2011 | 142 | 0.020 |
Why?
|
| Forelimb | 2 | 1978 | 14 | 0.020 |
Why?
|
| Spiral Ganglion | 1 | 2008 | 11 | 0.020 |
Why?
|
| Quinoxalines | 1 | 2008 | 39 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2008 | 119 | 0.020 |
Why?
|
| Hair Cells, Auditory | 1 | 2008 | 64 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 1872 | 0.020 |
Why?
|
| Muscle Cells | 1 | 2007 | 24 | 0.020 |
Why?
|
| Computational Biology | 1 | 2012 | 800 | 0.020 |
Why?
|
| Stem Cells | 2 | 2004 | 701 | 0.020 |
Why?
|
| Neurotoxins | 1 | 2007 | 56 | 0.020 |
Why?
|
| Ethics, Research | 1 | 2007 | 50 | 0.020 |
Why?
|
| Young Adult | 2 | 2011 | 8870 | 0.020 |
Why?
|
| Neurosurgical Procedures | 1 | 2009 | 297 | 0.020 |
Why?
|
| Pharmacogenetics | 1 | 2007 | 183 | 0.020 |
Why?
|
| Algorithms | 1 | 2013 | 1597 | 0.020 |
Why?
|
| Small-Conductance Calcium-Activated Potassium Channels | 1 | 2005 | 13 | 0.020 |
Why?
|
| Synapsins | 1 | 2004 | 6 | 0.020 |
Why?
|
| Biomechanical Phenomena | 1 | 1986 | 246 | 0.020 |
Why?
|
| Cell Communication | 1 | 2005 | 165 | 0.020 |
Why?
|
| Disks Large Homolog 4 Protein | 1 | 2004 | 16 | 0.020 |
Why?
|
| Guanylate Kinases | 1 | 2004 | 17 | 0.020 |
Why?
|
| Hydroxydopamines | 1 | 1984 | 5 | 0.010 |
Why?
|
| N-Methylaspartate | 1 | 2004 | 29 | 0.010 |
Why?
|
| Genome, Human | 1 | 2011 | 1267 | 0.010 |
Why?
|
| Contactins | 1 | 2004 | 3 | 0.010 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-1 | 1 | 2004 | 31 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 2108 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2007 | 1211 | 0.010 |
Why?
|
| NAV1.6 Voltage-Gated Sodium Channel | 1 | 2004 | 17 | 0.010 |
Why?
|
| Electromyography | 1 | 2004 | 160 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 2005 | 261 | 0.010 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2003 | 7 | 0.010 |
Why?
|
| Cytochromes c | 1 | 2003 | 51 | 0.010 |
Why?
|
| Cathepsin L | 1 | 2003 | 11 | 0.010 |
Why?
|
| X Chromosome | 1 | 2004 | 337 | 0.010 |
Why?
|
| Dwarfism | 1 | 2004 | 101 | 0.010 |
Why?
|
| GABA Antagonists | 1 | 2003 | 20 | 0.010 |
Why?
|
| Research Design | 1 | 2007 | 688 | 0.010 |
Why?
|
| RNA | 2 | 1997 | 577 | 0.010 |
Why?
|
| Spatial Behavior | 1 | 2003 | 15 | 0.010 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 2003 | 22 | 0.010 |
Why?
|
| International Agencies | 1 | 2002 | 28 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 5048 | 0.010 |
Why?
|
| Molecular Biology | 1 | 2002 | 77 | 0.010 |
Why?
|
| Light | 1 | 2003 | 175 | 0.010 |
Why?
|
| Acetylation | 1 | 2002 | 165 | 0.010 |
Why?
|
| Maze Learning | 1 | 2002 | 125 | 0.010 |
Why?
|
| Lysosomes | 1 | 2003 | 232 | 0.010 |
Why?
|
| United States | 2 | 2011 | 10618 | 0.010 |
Why?
|
| Gene Dosage | 1 | 2003 | 441 | 0.010 |
Why?
|
| Calcium-Binding Proteins | 1 | 2003 | 327 | 0.010 |
Why?
|
| Hypertrophy | 1 | 1981 | 100 | 0.010 |
Why?
|
| Tetraethylammonium | 1 | 2000 | 9 | 0.010 |
Why?
|
| Genetic Complementation Test | 1 | 2001 | 86 | 0.010 |
Why?
|
| Shaw Potassium Channels | 1 | 2000 | 8 | 0.010 |
Why?
|
| Fear | 1 | 2002 | 202 | 0.010 |
Why?
|
| Social Behavior | 1 | 2002 | 207 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 6372 | 0.010 |
Why?
|
| Prognosis | 1 | 2010 | 4508 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2002 | 752 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2001 | 757 | 0.010 |
Why?
|
| Tremor | 1 | 2001 | 129 | 0.010 |
Why?
|
| Twins | 1 | 1979 | 68 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2003 | 935 | 0.010 |
Why?
|
| Mexican Americans | 1 | 2000 | 204 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2001 | 609 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 1998 | 30 | 0.010 |
Why?
|
| Corneal Opacity | 1 | 1998 | 23 | 0.010 |
Why?
|
| Mitochondria | 1 | 2003 | 680 | 0.010 |
Why?
|
| Adaptor Protein Complex 3 | 1 | 1998 | 2 | 0.010 |
Why?
|
| Adaptor Protein Complex beta Subunits | 1 | 1998 | 2 | 0.010 |
Why?
|
| Association Learning | 1 | 1998 | 20 | 0.010 |
Why?
|
| Contingent Negative Variation | 1 | 1978 | 2 | 0.010 |
Why?
|
| Injections, Intraventricular | 1 | 1998 | 65 | 0.010 |
Why?
|
| Wounds, Stab | 1 | 1998 | 38 | 0.010 |
Why?
|
| Cell Division | 1 | 2000 | 779 | 0.010 |
Why?
|
| Gerbillinae | 1 | 1998 | 55 | 0.010 |
Why?
|
| Gliosis | 1 | 1998 | 32 | 0.010 |
Why?
|
| Occipital Lobe | 1 | 1978 | 32 | 0.010 |
Why?
|
| Auditory Perception | 1 | 1978 | 35 | 0.010 |
Why?
|
| Tubocurarine | 1 | 1977 | 4 | 0.010 |
Why?
|
| Motor Endplate | 1 | 1977 | 15 | 0.010 |
Why?
|
| Genes, fos | 1 | 1997 | 17 | 0.010 |
Why?
|
| Phrenic Nerve | 1 | 1977 | 11 | 0.010 |
Why?
|
| Hot Temperature | 1 | 1998 | 135 | 0.010 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 1998 | 101 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 1998 | 204 | 0.010 |
Why?
|
| Ion Transport | 1 | 1997 | 49 | 0.010 |
Why?
|
| snRNP Core Proteins | 1 | 1997 | 8 | 0.010 |
Why?
|
| Penicillins | 1 | 1978 | 154 | 0.010 |
Why?
|
| Paternity | 1 | 1997 | 8 | 0.010 |
Why?
|
| Diffusion | 1 | 1977 | 58 | 0.010 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2000 | 382 | 0.010 |
Why?
|
| Mice, Inbred NOD | 1 | 1997 | 285 | 0.010 |
Why?
|
| Diaphragm | 1 | 1977 | 97 | 0.010 |
Why?
|
| Neoplasms | 1 | 2011 | 2766 | 0.010 |
Why?
|
| Aneuploidy | 1 | 1997 | 152 | 0.010 |
Why?
|
| Gene Rearrangement | 1 | 1998 | 326 | 0.010 |
Why?
|
| Anxiety | 1 | 2003 | 956 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 135 | 0.010 |
Why?
|
| Evoked Potentials, Auditory | 1 | 1993 | 52 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1993 | 258 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1993 | 287 | 0.010 |
Why?
|
| Fibroblasts | 1 | 1997 | 878 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 1994 | 441 | 0.010 |
Why?
|
| Animals, Wild | 1 | 1992 | 24 | 0.010 |
Why?
|
| Pregnancy | 1 | 1979 | 7124 | 0.000 |
Why?
|
| Obesity | 1 | 1997 | 2229 | 0.000 |
Why?
|